| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
300.33(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
80,031 |
461,916 |
540,416 |
831,596 |
| Total Sell Value |
$14,256,265 |
$81,646,316 |
$93,320,391 |
$138,453,569 |
| Total People Sold |
2 |
9 |
9 |
12 |
| Total Sell Transactions |
2 |
11 |
13 |
29 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
• – – |
2013-08-16 |
4 |
OE |
$28.91 |
$326,590 |
D/D |
10,475 |
256,224 |
|
- |
|
| Hurwich Thomas A. |
VP, Controller |
• – – |
2013-08-14 |
4 |
D |
$44.93 |
$410,570 |
D/D |
(9,138) |
50,783 |
|
- |
|
| Hurwich Thomas A. |
VP, Controller |
• – – |
2013-08-14 |
4 |
OE |
$27.15 |
$316,683 |
D/D |
11,503 |
59,921 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2013-08-12 |
4 |
S |
$45.01 |
$225,307 |
D/D |
(5,006) |
64,237 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2013-08-12 |
4 |
OE |
$24.07 |
$164,708 |
D/D |
6,842 |
69,243 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2013-08-09 |
4 |
D |
$45.06 |
$117,967 |
D/D |
(2,618) |
62,401 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2013-08-09 |
4 |
S |
$44.78 |
$172,176 |
D/D |
(3,845) |
65,019 |
|
- |
|
| Saleki-Gerhardt Azita |
SVP, Operations |
• – – |
2013-08-09 |
4 |
OE |
$22.94 |
$242,993 |
D/D |
9,592 |
68,864 |
|
- |
|
| Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
• – – |
2013-08-01 |
4 |
D |
$45.48 |
$247,548 |
D/D |
(5,443) |
245,749 |
|
- |
|
| Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
• – – |
2013-08-01 |
4 |
OE |
$32.57 |
$208,721 |
D/D |
6,408 |
251,192 |
|
- |
|
| Burnside William H.l. |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
2,535 |
|
- |
|
| Liddy Edward M |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
7,656 |
|
- |
|
| Waddell Frederick H |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
4,535 |
|
- |
|
| Roberts Roy S |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
22,535 |
|
- |
|
| Tilton Glenn F |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
21,741 |
|
- |
|
| Rapp Edward J |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
5,035 |
|
- |
|
| Austin Roxanne S |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
25,601 |
|
- |
|
| Alpern Robert J |
Director |
– • – |
2013-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,535 |
11,094 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2013-05-01 |
4 |
S |
$45.66 |
$5,191,389 |
D/D |
(113,656) |
176,079 |
|
- |
|
| Alban Carlos |
EVP, Commercial Operations |
• – – |
2013-05-01 |
4 |
OE |
$26.85 |
$3,994,052 |
D/D |
142,900 |
289,735 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2013-03-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
10 |
284,053 |
|
- |
|
| Gonzalez Richard A |
Chairman of the Board and CEO |
• • – |
2013-03-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,243 |
284,063 |
|
- |
|
| Leonard John M. |
SVP, Chief Scientific Officer |
• – – |
2013-03-15 |
4 |
S |
$38.45 |
$1,795,615 |
D/D |
(46,700) |
107,320 |
|
- |
|
| Leonard John M. |
SVP, Chief Scientific Officer |
• – – |
2013-03-15 |
4 |
OE |
$28.86 |
$1,347,893 |
D/D |
46,700 |
154,020 |
|
- |
|
| Rapp Edward J |
Director |
– • – |
2013-03-11 |
4 |
B |
$37.66 |
$94,169 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
765 Records found
|
|
Page 29 of 31 |
|
|
1.09 (0.65%) 
